Premium
The effects of anti‐hypertensives and type 2 diabetes on salivary flow and total antioxidant capacity
Author(s) -
Djukić LJ,
Roganović J,
Brajović MD,
Bokonjić D,
Stojić D
Publication year - 2015
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12325
Subject(s) - metoprolol , enalapril , medicine , hydrochlorothiazide , endocrinology , saliva , diabetes mellitus , type 2 diabetes , pharmacology , angiotensin converting enzyme , blood pressure
Objective The present cross‐sectional study aimed to determine the effect of first‐line anti‐hypertensive drugs (enalapril, metoprolol, and combinations of enalapril with metoprolol and/or hydrochlorothiazide) on salivary gland function and salivary total antioxidant capacity ( TAC ) in hypertensive patients with/without diabetes mellitus ( DM ) type 2. Materials and Methods Salivary gland function was measured as xerostomia (interview) and unstimulated whole saliva flow rate ( UWSFR ) in 447 subjects (387 hypertensive and 60 healthy). Salivary TAC was evaluated by spectrophotometric assay. Results Enalapril is not xerogenic, while metoprolol and drug combinations are. In the presence of DM type 2, all drugs, except metoprolol, had pronounced xerogenic effect. Binary logistic regression analysis found enalapril to be significantly associated with decreased risk of xerogenic effect development, while DM type 2 with increased risk. In the presence of enalapril in hypertensive patients with/without DM type 2 salivary TAC was similar to that in healthy subjects, while for metoprolol was reduced. Conclusions Enalapril is not xerogenic but is antioxidant, which moderately reduces the risk of xerogenic effect development even in the presence of DM type 2. However, metoprolol and drug combinations exhibit xerogenic effect. In DM type 2, xerogenic effect of all drugs was pronounced except of metoprolol.